This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al. WHO-EORTC classification for cutaneus lymphomas. Blood 2005; 105: 3678–3685.
Garnache-Ottou F, Feuillard J, Saas P . Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? Br J Haematol 2007; 136: 539–548.
Feuillard J, Jacob MC, Valenci F, Maynadiè M, Gressin R, Chaperot L et al. Clinical and biologic features of CD4+ CD 56+ malignancies. Blood 2002; 99: 1556–1563.
Reimer P, Rüdiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A et al. What is CD4+ CD56+ malignancy and how should it be treated? Bone Marrow Transplant 2003; 32: 637–646.
Schmid C, Labopin M, Nagler A, Bornhäuser M, Finke J, Fassas A et al. Donor lymphocyte Infusion in the treatment of first haematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukaemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 2007; 25: 4938–4945.
Ghaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210–3217.
Chaperot L, Perrot I, Jacob MC, Blanchard D, Salaun V, Deneys V et al. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol 2004; 34: 418–426.
Hanabuchi S, Watanabe N, Wang YH, Wang YH, Ito T, Shaw J et al. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006; 107: 3617–3623.
Naranjo-Gómez M, Oliva H, Climent N, Fernàndez MA, Ruiz-Riol M, Bofill M et al. Expression and function of IL-2 receptor in activated human plasmatoid dendritic cells. Eur J Immunol 2007; 37: 1764–1772.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kaloyannidis, P., Zomas, A., Paterakis, G. et al. GVL effect in plasmacytoid DC leukemia/lymphoma. Bone Marrow Transplant 45, 961–962 (2010). https://doi.org/10.1038/bmt.2009.270
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.270
This article is cited by
-
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
Leukemia (2023)
-
Dendritic Cell Leukemia: a Review
Current Oncology Reports (2020)
-
Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation—a single center experience
Annals of Hematology (2015)
-
Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm
Bone Marrow Transplantation (2013)